TransMedTech Institute aims to support the development of innovative medical technologies, train the next generation of professionals and make innovation in life sciences and engineering a source of wealth for society. Based on a Living Lab approach, TransMedTech provides an integrated environment that supports interdisciplinary collaborative processes and co-creation of new medical technologies and interventions to catalyze their development and adoption by users.
With a total of $95 million in grants from the Fonds d'excellence en recherche Apogée Canada, the Fonds de recherche du Québec, the Ministère de l'Économie et de l'Innovation du Québec and several other partners, TransMedTech Institute is led by 5 founding institutions (Polytechnique Montréal, University of Montréal, CHU Sainte-Justine, CHUM and Jewish General Hospital of Montreal), includes over 50 partner institutions and has first-rate infrastructure to support the development and validation of medical technologies.
The mission of the TransMedTech Institute team is to:
- Support the accelerated development of next-generation medical technologies applied to three broad categories of diseases (cardiovascular, neuro-musculoskeletal and cancers) in order to facilitate their implementation in the health system.
- Train the next generation of medical technology professionals.
- Make innovation in life sciences and engineering a source of wealth for society.
TransMedTech in numbers
- $28 million: value of 115 supported research projects
- 75 researchers from several universities and major teaching hospitals
- 97 scholarship students
- 19 highly qualified professionnals working in 16 subsidized technology platforms